Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Development Center for Biotechnology (DCB) is a prominent non-profit research and development organization based in Taiwan, dedicated to bridging the gap between basic research and commercialization in the life sciences. DCB focuses on the development of biologics, including monoclonal antibodies and antibody-drug conjugates (ADCs), as well as small molecule drugs and cell therapies. The center operates as a key incubator for Taiwan's biotech industry, providing preclinical testing, process development, and pilot manufacturing services. By partnering with academic institutions and global pharmaceutical companies, DCB facilitates the translation of innovative technologies into clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Development Center.